SANTA ANA, Calif .– (COMMERCIAL THREAD) – FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development and manufacture of cell culture media and assisted reproduction technologies (ART), today announced that it will become the sole distributor worldwide of Life Whisperer, the fertility arm of Presagen, a leader in the field of Artificial Intelligence (AI) health. Life Whisperer is a non-invasive, web-based software product that uses image-based analysis and AI to help the embryologist determine the viability of the embryo.
Although many factors affect the success rate of in vitro fertilization (IVF), the conventional method of determining embryonic viability by light microscopy may be subjective, and critical morphological features that indicate embryonic viability may be missed. Life Whisperer software can aid this process by analyzing high-resolution digital camera images taken of day 5 embryos to help identify morphological characteristics of the embryo that correlate with uterine implantation potential. The AI algorithm produces a confidence score that objectively indicates an embryo’s implantation potential to produce an objective and standardized embryonic viability score, thus aiding embryologists in their efforts to select embryos based on their likelihood. to lead to a successful pregnancy.
“Fujifilm is a leading medical imaging and AI company. We view Presagen’s emerging suite of AI-based fertility workflow tools as a strong addition to our portfolio of ART product offerings and aligned with Fujifilm’s broader commitment to AI.” said Tim Mullane, President and COO of FUJIFILM Irvine Scientific.
“FUJIFILM Irvine Scientific continues to be the leader in providing innovative technologies to help meet the challenges faced in IVF in an effort to help build families., ” said Steven Geimer, Executive Director of the Medical Business Unit, FUJIFILM Irvine Scientific. “We believe that AI-based ART technology can have a significant impact on the embryo selection process by providing an objective tool that embryologists can use as part of their process to help increase the potential for pregnancy of an embryo. patient.. ”
Presagen has developed and implemented a healthcare information network that enables IVF clinics to access AI tools through the secure, real-time transfer of clinical medical data. This networking platform supported the development of the Life Whisperer embryonic viability tools.
“Presagen is committed to improving health through the implementation of artificial intelligence, ” said Dr Michelle Perugini, CEO and Co-Founder, Presagen. “The Life Whisperer tools were developed in collaboration with IVF clinics around the world. Additional fertility tools are under development and will be seamlessly integrated into our current AI platform. This AI application provides embryologists with an objective method of evaluating the quality of embryos to help them increase the chances of successful pregnancy for their patients.1”
The Life Whisperer embryonic viability product is expected to be available this summer through FUJIFILM Irvine Scientific and its existing distribution channels. The initial offering of the Life Whisperer embryonic viability product will be cleared for sale in a number of countries in Europe and Asia-Pacific. More countries are expected to be added as authorization for use by their respective regulatory authorities is received. Not for sale in the USA. For more information on using Life Whisperer and the current list of countries where it is available, please visit www.irvinesci.com/life-whisperer.
1. VerMilyea M, Hall JMM, Diakiw SM, et al. Development of an artificial intelligence-based assessment model for predicting embryonic viability using static images captured by light microscopy during IVF. Buzz reproduction. 2020; 35 (4): 770-784. doi: 10.1093 / humrep / deaa013
This product is a software application for the evaluation of embryo images, intended to be used for clinical decision support to aid in the selection of embryos during in vitro fertilization procedures (IVF). Not intended for use as a direct diagnosis.